{"id":7543,"date":"2023-01-16T11:32:40","date_gmt":"2023-01-16T11:32:40","guid":{"rendered":"https:\/\/cinmed.me\/o-cinmed-u\/medunarodna-saradnja\/twinning-projekat\/"},"modified":"2023-02-24T09:36:54","modified_gmt":"2023-02-24T09:36:54","slug":"twinning-project","status":"publish","type":"page","link":"https:\/\/cinmed.me\/en\/about-cinmed\/international-cooperation\/twinning-project\/","title":{"rendered":"TWINNING project"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Twinning\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/p>

The Institute for Medicines and Medical Devices (CInMED), a legal successor and continues the work of the Agency for Medicines and Medical Devices (CALIMS), as a responsible and efficient institution in the service of public health, is cooperating with partner institutions from the EU Member State Republic of Croatia on the Twinning project. The EU twinning element, defined as a development model that uses institution-to-institution partnerships and peer relationships to benefit both sides, shall accelerate the improvement of existing practices and legislation related to Pharmaceuticals and Medical Devices in Montenegro.<\/p>

\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Twinning is Flexible<\/b>.<\/strong><\/p>

Twinning is Collaborative.<\/b><\/strong><\/p>

Twinning Gets Results.<\/b><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n
\n\t\t\t\t\t
<\/i><\/span><\/i><\/span>About project<\/span><\/i><\/div>

This EU Twinning Project will play a key role in strengthening CInMED\u2019s administrative capacity by delivering a well-targeted mix of capacity building activities \u2013 consisting of tailored training, on-the-job assistance, workshops and study visits \u2013 that will mainly consist of the transfer of knowledge on the latest EU work guidelines and feedback on examples of good practices (as well as on mistakes to be avoided). Strengthening of CInMED\u2019s administrative capacity will be of great importance for the fulfilment of another closing benchmark in Chapter 1 related to the obligation of Montenegro to demonstrate that it has the adequate administrative capacity to properly implement and enforce legislation transposing New, Global, and Old Approach product acquis, by the time of accession. At the same time, it is widely perceived that it is necessary to further improve corporate knowledge and competencies, both at strategic and operational levels.<\/p>

\u00a0<\/p>

Another value of this Twinning will be the provision of EU Member State expert assistance to CInMED in performing a very challenging task of drafting a comprehensive, clear and fully aligned set of rules and guidelines. This is of great importance for meeting the first closing benchmark, as the assessment of its fulfilment will be possible only after all the relevant secondary legislation is adopted i.e. after the national legislation is aligned with the EU acquis relating to medicinal products for human and veterinary use.<\/p>

\u00a0<\/p>

Similarly, the Twinning support is expected to help CInMED\u2019s familiarisation with newly-entrusted tasks, such as GMP, GVP, GCP and GDP inspections, as well as to provide advice in designing effective working tools and in developing the necessary technical and soft skills.<\/p>

\u00a0<\/p>

The operational approach will build upon previously gained theoretical knowledge and hands-on expertise acquired by CInMED\u2019s staff in the past 10 years and will be beneficial in terms of increased ability to perform daily duties. CInMED\u2019s commitment to work according to the highest ethical, professional and quality standards is attested, as well as the joint efforts of its employees to soundly apply the EU and internationally acknowledged good practices.<\/p>

\u00a0<\/p>

\u00a0<\/p>

\u00a0PROJECT IMPLEMENTATION <\/strong>PERIOD:
\u00a0<\/strong>29 January 2021 \u2013 28 July 2022 <\/strong><\/p>

(18 months)<\/strong><\/p>

\u00a0<\/p>

THIS TWINNING IS FOCUSED ON THREE MAIN COMPONENTS:<\/strong><\/p>

\u00a0<\/p>

Component 1<\/strong> \u2013 CInMED Institutional Capacity and Visibility strengthened<\/em><\/p>